Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

2021114 citationsJournal Articlebronze Open Access

Authors

Mayte Sánchez van Kammen · University of Amsterdam

Diana Aguiar de Sousa · University of Lisbon

Sven Poli · Hertie Institute for Clinical Brain Research

Charlotte Cordonnier

Mirjam R. Heldner · University of Bern

Anita van de Munckhof · University of Amsterdam

Katarzyna Krzywicka · University of Amsterdam

Abstract

In this cohort study of patients with CVST, a distinct clinical profile and high mortality rate was observed in patients meeting criteria for TTS after SARS-CoV-2 vaccination.

Topics & Keywords

Heparin-Induced Thrombocytopenia and Thrombosis Venous Thromboembolism Diagnosis and Management Cerebral Venous Sinus Thrombosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Neurology

Volume 78, Issue 11, pp. 1314-1314

DOI: 10.1001/jamaneurol.2021.3619

Field-Weighted Citation Impact: 22.58